Ismail, E., Nofal, O. K. J., Sakthiswary, R., Shaharir, S. S., & Sridharan, R. (2016). The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis. PLoS One.
Citação norma ChicagoIsmail, Endom, Omimah Khaled Jaber Nofal, Rajalingham Sakthiswary, Syahrul Sazliyana Shaharir, e Radhika Sridharan. "The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis." PLoS One 2016.
Citação norma MLAIsmail, Endom, et al. "The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis." PLoS One 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.